XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Oct 31, 2024 | (FY)Apr 30, 2024 | (Q6)Oct 31, 2023 | (FY)Apr 30, 2023 | (Q6)Oct 31, 2022 | (FY)Apr 30, 2022 | (Q6)Oct 31, 2021 | (FY)Apr 30, 2021 | (Q6)Oct 31, 2020 | (FY)Apr 30, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -3.92%1.27B | -4.92%2.69B | -4.63%1.32B | -3.25%2.83B | 5.51%1.39B | 8.48%2.92B | -0.54%1.31B | 5.90%2.69B | 13.75%1.32B | 8.17%2.54B |
Operating income | -3.92%1.27B | -4.92%2.69B | -4.63%1.32B | -3.25%2.83B | 5.51%1.39B | 8.48%2.92B | -0.54%1.31B | 5.90%2.69B | 13.75%1.32B | 8.17%2.54B |
Cost of sales | 4.22%-673.95M | 5.87%-1.43B | 4.87%-703.67M | 4.51%-1.51B | -5.99%-739.71M | -7.46%-1.59B | 3.54%-697.89M | -8.67%-1.48B | -16.91%-723.51M | -6.97%-1.36B |
Operating expenses | 4.22%-673.95M | 5.87%-1.43B | 4.87%-703.67M | 4.51%-1.51B | -5.99%-739.71M | -7.46%-1.59B | 3.54%-697.89M | -8.67%-1.48B | -16.91%-723.51M | -6.97%-1.36B |
Gross profit | -3.58%596.68M | -3.82%1.26B | -4.35%618.82M | -1.74%1.31B | 4.95%646.95M | 9.71%1.33B | 3.08%616.42M | 2.73%1.22B | 10.16%597.99M | 9.58%1.18B |
Selling expenses | 1.37%-27.49M | 28.00%-60.83M | 31.74%-27.87M | -13.01%-84.49M | -25.19%-40.84M | -10.74%-74.77M | -7.00%-32.62M | -5.34%-67.51M | -4.80%-30.48M | -8.31%-64.09M |
Administrative expenses | 0.56%-528.79M | -3.78%-1.08B | -5.79%-531.77M | -0.99%-1.04B | -1.96%-502.67M | -4.85%-1.03B | -5.62%-493.02M | -4.10%-980.39M | -1.55%-466.81M | -4.57%-941.81M |
Special items of operating profit | -18.88%6.46M | -60.97%14.3M | -75.34%7.97M | -20.56%36.63M | 12.59%32.31M | -66.20%46.1M | -71.08%28.7M | 553.14%136.4M | 662.01%99.21M | 18.24%20.88M |
Operating profit | -30.21%46.86M | -39.05%137.42M | -50.54%67.15M | -18.93%225.45M | 13.64%135.76M | -8.82%278.12M | -40.24%119.47M | 53.16%305M | 197.97%199.91M | 43.77%199.14M |
Financing income | -30.51%3.1M | 29.91%7.89M | 141.05%4.46M | 877.62%6.07M | 465.44%1.85M | -78.69%621K | -85.87%327K | -43.29%2.91M | -18.64%2.31M | -11.43%5.14M |
Financing cost | -6.78%-12.59M | -45.54%-25.54M | -45.32%-11.79M | -4.93%-17.55M | 6.78%-8.11M | 17.29%-16.72M | 13.71%-8.7M | 7.94%-20.22M | 10.69%-10.09M | -2,558.96%-21.96M |
Earning before tax | -37.53%37.36M | -44.03%119.77M | -53.81%59.81M | -18.33%213.98M | 16.56%129.5M | -8.93%262.01M | -42.18%111.09M | 57.80%287.7M | 227.66%192.13M | 27.06%182.32M |
Tax | 32.54%-7.35M | 37.79%-19.97M | 44.51%-10.89M | 23.01%-32.1M | -30.96%-19.63M | -39.65%-41.7M | 27.11%-14.99M | -13.72%-29.86M | -111.90%-20.57M | -4.09%-26.26M |
After-tax profit from continuing operations | -38.64%30.02M | -45.13%99.8M | -55.47%48.92M | -17.45%181.88M | 14.32%109.87M | -14.55%220.32M | -43.98%96.1M | 65.22%257.84M | 250.62%171.57M | 31.95%156.06M |
Earning after tax | -38.64%30.02M | -45.13%99.8M | -55.47%48.92M | -17.45%181.88M | 14.32%109.87M | -14.55%220.32M | -43.98%96.1M | 65.22%257.84M | 250.62%171.57M | 31.95%156.06M |
Minority profit | -59.60%-2.94M | -518.75%-1.27M | -280.99%-1.84M | 160.32%304K | -150.26%-484K | -117.24%-504K | -55.87%963K | -43.08%2.92M | 173.78%2.18M | 757.75%5.14M |
Profit attributable to shareholders | -35.07%32.96M | -44.34%101.07M | -54.00%50.76M | -17.77%181.57M | 15.99%110.35M | -13.38%220.82M | -43.83%95.14M | 68.90%254.92M | 251.90%169.39M | 26.77%150.93M |
Basic earnings per share | -35.13%0.0458 | -44.66%0.14 | -54.07%0.0706 | -17.86%0.253 | 15.91%0.1537 | -13.48%0.308 | -44.05%0.1326 | 68.72%0.356 | 251.63%0.237 | 27.11%0.211 |
Diluted earnings per share | -34.81%0.0457 | -44.22%0.14 | -54.09%0.0701 | -17.97%0.251 | 15.77%0.1527 | -13.31%0.306 | -44.02%0.1319 | 68.10%0.353 | 252.17%0.2356 | 27.27%0.21 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.